Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Stock-Based Compensation Expense) (Details)

v3.24.2.u1
Stockholders' Equity (Stock-Based Compensation Expense) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense $ 4,998 $ 4,217 $ 9,856 $ 8,948
Avenue Therapeutics, Inc [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense 192 27 383 38
Checkpoint [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense 1,171 567 1,881 1,536
Mustang        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense (619) 45 (542) 280
Journey        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense 1,674 873 3,080 1,519
Other Partners [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense 58 24 115 50
Employee and non-employee awards        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense 2,249 2,271 4,442 4,708
Executive awards        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense $ 273 $ 410 $ 497 $ 817